Advice

Recommended for general use within NHSScotland.

Risedronate sodium (Actonel®) is a once weekly formulation which offers a convenient, cost neutral alternative to once daily medication for the prophylaxis and treatment of osteoporosis in post menopausal women.

Download detailed advice16KB (PDF)

Download

Medicine details

Medicine name:
Risedronate sodium (Actonel®)
SMC ID:
46/03
Indication:
Osteoporosis in post menopausal women
Pharmaceutical company
Procter and Gamble
BNF chapter
Endocrine system
Submission type
Abbreviated
Status
Superseded
Date advice published
09 May 2003
Additional notes

NICE MTA Advice:  SMC Advice is superseded by National Institute for Health and Clinical Excellence (NICE) Multiple Technology Appraisal (MTA)